Again, a study suggests chronic use of selective COX-2 inhibitors (COXIBs) may lead to myocardial infarction.27 Developing medications that preferentially inhibit COX-2 over COX-1 can be difficult since both isoforms have very similar molecular weights, sites of cellular expression, and amino acid compositions. This evidence concerns the gene PTGS2 and myocardial infarction.